Sign Up to like & get
recommendations!
2
Published in 2021 at "Movement Disorders"
DOI: 10.1002/mds.28541
Abstract: Functional brain connectivity alterations may be detectable even before the occurrence of brain atrophy, indicating their potential as early markers of pathological processes.
read more here.
Keywords:
drug parkinson;
functional connectomics;
connectomics disease;
connectomics ... See more keywords
Sign Up to like & get
recommendations!
2
Published in 2022 at "Life sciences"
DOI: 10.1016/j.lfs.2022.120437
Abstract: Chronic myeloid leukemia (CML) is a cancer of the bone marrow characterized by an uncontrolled increase in the production of myeloid cells. MicroRNAs (miRNAs) are a group of non-coding RNA molecules with a length of…
read more here.
Keywords:
development progression;
cml;
myeloid leukemia;
role ... See more keywords
Sign Up to like & get
recommendations!
3
Published in 2023 at "Cancer Research"
DOI: 10.1158/1538-7445.am2023-sy26-01
Abstract: Cellular plasticity is emerging as an important driving force underlying cancer progression and drug resistance. In this talk, I will discuss the concept of cancer cell states present in the tumor prior to treatment, as…
read more here.
Keywords:
cancer;
progression drug;
resistance;
cellular plasticity ... See more keywords
Sign Up to like & get
recommendations!
0
Published in 2020 at "International Journal of Molecular Sciences"
DOI: 10.3390/ijms21093084
Abstract: MicroRNAs (miRNAs, or miRs) are single-strand short non-coding RNAs with a pivotal role in the regulation of physiological- or disease-associated cellular processes. They bind to target miRs modulating gene expression at post-transcriptional levels. Here, we…
read more here.
Keywords:
drug resistance;
disease;
multiple myeloma;
progression drug ... See more keywords